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Commensal microbes are necessary for a healthy gut
immune system. However, the mechanism involving
these microbes that establish and maintain gut im-
mune responses is largely unknown. Here, we have
found that the gut immune receptor leucine-rich
repeat (LRR) C19 is involved in host-microbiota
interactions. LRRC19 deficiency not only impairs
the gut immune system but also reduces inflamma-
tory responses in gut tissues. We demonstrate that
the LRRC19-associated chemokines CCL6, CCL9,
CXCL9, and CXCL10 play a critical role in immune
cell recruitment and intestinal inflammation. The
expression of these chemokines is associated with
regenerating islet-derived (REG) protein-mediated
microbiotas. We also found that the expression of
REGsmay be regulated by gut Lactobacillus through
LRRC19-mediated activation of NF-kB. Therefore,
our study establishes a regulatory axis of LRRC19,
REGs, altered microbiotas, and chemokines for the
recruitment of immune cells and the regulation of
intestinal inflammation.
INTRODUCTION
The gut lymphoid system constitutes the largest part of the
whole immune system and includes organized tissues such as
Peyer patches (PPs) and the mesenteric lymph nodes (MLNs)
as well as lymphoid tissues scattered throughout the lamina
propria (LP) and the epithelium of the mucosa (Mowat and Viney,
1997). This gut immune system contains both innate immune
cells, such as dendritic cells (DCs), macrophages, and immature
myeloid cells, and adaptive immune cells, such as CD4 and CD8
lymphocytes and their subsets, including Th1, Th17, regulatory
T (Treg), Th17+Foxp3+, and innate T cells. These cells perform
crucial roles in protecting the body from foreign pathogens andCestablishing the immunological tolerance in the gut tissues.
However, the exact mechanisms underlying recruitment, reten-
tion, and differentiation of these immune cells in gut tissues are
unclear. Studies have suggested that microbe-recognizing mol-
ecules expressed on intestinal epithelial cells can mediate gut
microbe-host immune cross-talk, integrating and transmitting
signals from bacteria to the mucosal innate and adaptive im-
mune cells (Goto and Ivanov, 2013). When the host lacks path-
ogen-recognizing molecules, such as myeloid differentiation
primary response gene 88 (MyD88, an adaptor molecule in the
Toll-like receptor [TLR] signaling pathway), nucleotide-binding
oligomerization domain-containing protein 2 (NOD2), or NOD1,
it is unable to clear invading pathogens from the gut tissue (Jiang
et al., 2013; Luddy et al., 2014). However, under normal physio-
logical conditions, intestinal epithelial cells show only low-level
expression of these pathogen-recognizing receptors, which
are generally unresponsive to TLR stimuli (Abreu et al., 2001;
Melmed et al., 2003), suggesting that these receptors are not
essential for the establishment and maintenance of the gut im-
mune system (de Kivit et al., 2014).
Commensal bacteria are necessary for gut immune responses
and inflammation under normal physiological conditions. These
commensal microbes develop together with the gut immune sys-
tem from birth and play a crucial role in the maturation of the in-
testinal mucosal immune system of their host (Clemente et al.,
2012). Indeed, germ-free (GF) mice differ from normal mice in
the number of DCs and innate lymphoid cells, although all major
innate immune subsets are present in these mice (Niess and
Adler, 2010; Sawa et al., 2010). Additionally, the absence of in-
testinal bacteria in GF mice may dramatically reduce the fre-
quency of oncogenic mutations and tumor formation (Dove
et al., 1997; Li et al., 2012). Fecal and bacteria transplantations
have demonstrated that the gut microbiota can restore the num-
ber of immune cell populations in the gut immune system (Round
and Mazmanian, 2009) and the gut’s sensitivity to tumor-
inducing factors (Zhan et al., 2013). Recent studies have also
shown that commensal bacterial composition can influence the
type and robustness of the host’s immune responses (Ivanov
and Honda, 2012). The immunomodulatory roles of severalell Reports 14, 695–707, February 2, 2016 ª2016 The Authors 695
commensal bacterial species have been demonstrated (Ivanov
and Honda, 2012). However, how these gut commensal mi-
crobes exert their effects on the gut immune response and
inflammation is largely unknown.
LRRC19 belongs to the leucine-rich repeat (LRR) family and
differs from other pathogen-recognizing receptors because it
contains no cytoplasmic Toll/interleukin 1 (IL-1) receptor (TIR)
domain. LRRC19 is highly expressed in gut epithelial cells under
normal physiological conditions and is activated by multiple TLR
ligands and E. coli (Chai et al., 2009; Su et al., 2014). Here we
found that LRRC19 is involved in gut host-microbiota interac-
tions and that it plays a critical role in promoting the recruitment
of immune cells and intestinal inflammation.
RESULTS
LRRC19 Deficiency Reduces Inflammatory Responses
in Gut Tissues
Our previous studies have suggested that gut epithelial cells ex-
press LRRC19 (Chai et al., 2009; Su et al., 2014). Here we used
RT-PCR, in situ hybridization, and immunostaining to confirm
these findings (Figures S1A–S1C). LRR family members such
as TLRs, which are expressed in gut epithelial cells, play a signif-
icant role in enteritis, colitis, colon cancer, and metabolism-
associated diseases (Rakoff-Nahoum et al., 2006; Vijay-Kumar
et al., 2010). Because LRRC19 belongs to the LRR family, we first
undertook a long-term observational study of Lrrc19 knockout
(KO) mice to determine the effects of LRRC19 on mouse health.
Lrrc19 KO mice displayed increased longevity compared with
the cohoused wild-type (WT) littermates. Almost all Lrrc19 KO
(male and female) mice remained alive, whereas most of the
WT mice (>80%) had died after 2 years on standard chow (Fig-
ure 1A). Lrrc19 KO mouse body weights were lower than those
of WT mice (Figure 1A). Interestingly, when the gut tissues of
these mice were examined, almost all WT mice showed slight
inflammation (low-grade enteritis and colitis) whereas Lrrc19
KO mouse gut tissues did not. The gut tissues of Lrrc19 KO
mice were more yellow (Figure 1B) and the colon tissues were
thinner in Lrrc19 KO mice than in WT mice, and the ceca of
Lrrc19 KO mice were enlarged significantly (Figure 1C), as in
GF mice (Aluwihare, 1971). These features of Lrrc19 KO mice
suggest a lack of immunological inflammatory responses in their
gut tissues. Expression of cytokines such as tumor necrosis fac-
tor a (TNF-a), IL-1b, IL-6, interferon g (IFNg), IL-17, and IL-12was
lower in the gut tissues of Lrrc19 KO mice than in those of WT
mice over the long term (Figure 1D). Colitis-associated phos-
pho-nuclear factor kB (NF-kB) p65, and -STAT3, which were de-
tected readily in WT mice, were barely detectable in Lrrc19 KO
mice (Figure 1D). A histological examination of the LP showed
a sparse stroma in Lrrc19 KO mice, and the colonic sections
from these mice showed no overt inflammatory infiltrate in the
LP, which was observed in most WT mice (Figure 1E). Prolifer-
ating cell nuclear antigen (PCNA), a proliferative cell marker,
was immunoreactive in numerous WT colon epithelial cells
but not in Lrrc19 KO mouse epithelial cells. b-Catenin and
cyclooxygenase 2 (COX2), colon cancer-associated markers,
were also detected more readily in WT mice compared with
Lrrc19 KO mice (Figure 1F). All of these data imply that696 Cell Reports 14, 695–707, February 2, 2016 ª2016 The AuthorsLRRC19 is associated with enteritis, colitis, and colitis-associ-
ated tumorigenesis.
We next used dextran sodium sulfate (DSS)-induced colitis
and an azoxymethane (AOM)-DSS-induced colon cancer model
to examine the effects of LRRC19 on the occurrence and devel-
opment of colitis and colon cancer. The results showed that
LRRC19 deficiency conferred a marked resistance to DSS-
mediated colitis. Although WT mice showed clear symptoms of
colitis after exposure to 2.0% DSS in their drinking water for
7 days, the colitis symptoms, including survival rate, weight
loss, colon shortening, and histology scores, were suppressed
significantly in the cohoused Lrrc19 KO mice (Figures 2A–2C).
In the AOM-DSS-induced colon cancer model, WT mice devel-
oped a high incidence of colon tumors in the distal to middle
colon, whereas no tumors were found in cohoused Lrrc19 KO
mice treated with the same protocol (Figures 2D–2F). The colon
cancer-associated markers proliferating cell nuclear antigen
(PCNA) and COX2 were also difficult to detect in Lrrc19 KO
mice (Figure 2G). 5-Bromo-2-deoxyuridine (BrdU) experiments
showed strong absorbance by colon epithelial cells of WT
mice but not by those of Lrrc19 KO mice (Figure 2G). These re-
sults indicated that LRRC19 functions in gut-related tumorigen-
esis. LRRC19 is difficult to detect in hematopoietic cells, but its
expression is induced in inflammatory environments (unpub-
lished data). Therefore, we assessed intrinsic hematopoietic
cell functions in colitis generation and development. WT/WT chi-
meras (WT bone marrow [BM] donor cells transplanted into
lethally irradiated WT recipients), but not cohoused KO/ko
chimeras (Lrrc19 KO BM donor cells transplanted into lethally
irradiated Lrrc19 KO recipients), responded effectively to DSS-
induced colitis, further confirming the role of LRRC19 in colitis
(data not shown). Notably, in Lrrc19 KO mice that received WT
bone marrow, the incidence and severity of colitis were signifi-
cantly lower than those of WT mice transplanted with Lrrc19
KO BM (Figures S1D–S1F), suggesting that epithelial but not
hematopoietic expression of LRCC19 is necessary for the proin-
flammatory role of LRRC19 in DSS colitis. Together, these data
indicate that LRRC19 deficiency impairs the inflammatory re-
sponses in gut tissues.
LRRC19 Deficiency Reduces the Recruitment of
Immune Cells
We next investigated the factor(s) that cause(s) the decreased
inflammation in Lrrc19 KO gut tissues. Lrrc19 KO gut tissues
and gut-associated lymphoid tissues from mice previously sub-
jected to long-term observation were examined again. We found
that Lrrc19KOmice had fewer and smaller gut tissue-associated
lymph node PPs compared with cohoused WT mice (Figures 3A
and 3B), indicating that fewer immune cells had accumulated in
their gut immune systems. Because immune cells such as DCs,
adaptive lymphocytes (including Th1 and Th17 cells), and immu-
noregulatory cells such as regulatory T (Treg) cells play critical
roles in colitis and colitis-associated cancer (Nguyen et al.,
2015), we examined the composition and absolute numbers
of immune cells in the LPs, PPs, and MLNs of WT and Lrrc19
KO mice. We found that the absolute numbers of CD4+ T cells,
CD8+ T cells, DCs (CD11c+MHCII+ cells), macrophages (F4/
80+MHCII+ cells), and immature myeloid cells (CD11b+Gr1+
Figure 1. LRRC19 Deficiency Inhibits the Occurrence and Development of Gut Inflammation
(A) Survival rates (top) and changes in body weight (bottom) ofWT (WT, n = 24 [female, 12; male, 12]) and Lrrc19 KO (L19KO, n = 24 [female, 12; male, 12]) mice on
standard chow.
(B and C) Morphology of gut and cecum from representative WT (B) and Lrrc19 KO (C) mice after eating standard chow for 2 years.
(D) qRT-PCR analyses (top) of TNF-a, IL-1b (IL1b), IL-6, IFNg (IFNg), IL-17, and IL-12 and immunoblot (bottom) of pp-65 and pSTAT3 in colon tissues of WT (n = 6)
and Lrrc19 KO (n = 6) mice after standard chow for 2 years. RE, relative expression; M, male; F, female.
(E) H&E staining of representativeWT and Lrrc19KOmouse colons after standard chow for 2 years. The green arrow indicates inflammatory response cells. Scale
bars, 40 mm.
(F) Immunostaining of PCNA, b-catenin, and COX2 in colon tissues of representative WT and Lrrc19 KO mice. The green arrows indicate PCNA, b-catenin, and
COX2. Scale bars, 40 mm.
*p < 0.05, **p < 0.01 (Wilcoxon’s test in A [top], ANOVA in A [bottom], t test in D; mean ± SD). See also Figure S1.cells) weremuch lower in the LPs of Lrrc19KOmice than in those
ofWTmice (Figure 3C). The smaller numbers of innate and adap-
tive immune cells in Lrrc19 KO mice were confirmed with immu-
nostaining (Figure S2). The absolute numbers of CD103+CD11b–
(CD103+ DCs), CD103+CD11b+ (double-positive [DP] DCs), and
CD103–CD11b+ (CD11b+ DCs) subsets were also lower in the
PPs of Lrrc19 KO mice compared with those of cohoused WT
mice (Figure 3D). However, the proportion of the CD11c+CD103+
DC subpopulation, which plays a critical role in maintaining
gut tolerance (Benson et al., 2007; Coombes et al., 2007), did
not decrease but, rather, increased in the PPs and MLNs ofCLrrc19 KO mice (Figure S3B). The proportion of CD11b+ DCs
(CD11C+CD103+CD11b+ and CD11c+CD11b+ cells) was lower
in Lrrc19 KO mice than in WT mice (Figure S3B), indicating that
there were fewer hematopoietic CD11b+ DCs in Lrrc19 KO
mice than in WT mice. Importantly, the absolute numbers of
adaptive lymphocytic subsets (Th1 and Th17 cells) in the PPs
and MLNs of Lrrc19 KO mice, which may promote inflammation
responses, were less compared with those of WT mice (Figures
3E and 3F). Th17 cell frequency in the PPs and MLNs was
also reduced markedly in Lrrc19 KO mice, whereas the Treg
(Foxp3+) cell proportion, which may suppress inflammationell Reports 14, 695–707, February 2, 2016 ª2016 The Authors 697
Figure 2. Lrrc19 KO Mice Are Highly Resistant to DSS-Induced Colitis
(A) Survival (top) and body weight (bottom) weremonitored after the start of DSS.WT (n = 18, male) and Lrrc19 KO (n = 18, male) mice were fed a 2%DSS solution
in drinking water for 7 days and then switched to regular drinking water.
(B) Length of WT and Lrrc19 KO colon tissues. Mice were sacrificed on day 7 after the start of DSS, and colon length was measured.
(legend continued on next page)
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responses, was increased (Figure S3D). Notably, the reduced
number of T cells and the reduction in the Th17 subpopulation
in Lrrc19 KO mice were limited to the gut tissue. Lrrc19 KO
and WT mice did not differ in the numbers of DCs or T cells in
their spleens. No similar phenomena were found in Tlr4 KO,
Tlr2 KO, or Myd88 KO mice (data not shown). These data sug-
gest that the decreased number of immune cells and their sub-
sets may be responsible for the reduced gut inflammation in
Lrrc19 KO mice.
Reduced Chemokine Levels in Lrrc19 KO Gut Tissues
Are Responsible for Fewer Gut Immune Cells
We next investigated the cause of the decreased number of im-
mune cells in Lrrc19 KO gut tissues. Previous studies have
shown that chemokines play a critical role in the recruitment
and retention of immune cells. However, for chemokines such
as MCP-1/CCL2, which plays roles in recruiting immune cells
to gut tissues (Popivanova et al., 2009), there was no remarkable
difference in CCL2 expression between cohoused WT and
Lrrc19 KO mice, especially in the levels of transcription (Fig-
ure 4B). To identify chemokines involved in recruiting immune
cells in gut tissues, we used a microarray to analyze the differen-
tial expression of genes in the gut epithelial cells of cohousedWT
and Lrrc19 KO mice. The expression of several chemokines,
including CCL6, CCL9, CXCL9, and CXCL10, was reduced
significantly in Lrrc19 KO mice (Figure 4A; http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE62487). The reduced
levels of chemokine expression in LRRC19-deficient epithelial
cells were confirmed further with qRT-PCR, immunoblotting,
and immunostaining (Figure 4B; data not shown). These chemo-
kines play a critical role in recruiting innate and adaptive immune
cells, including DCs, macrophages, and CD4+ and CD8+ T cells
(Asensio et al., 1999; Coelho et al., 2007; Harris et al., 2012;
Nu´n˜ez et al., 2010; Zhao et al., 2003). Indeed, administration of
CCL6-, CCL9-, CXCL9-, and CXCL10-expressing adenoviral
complexes could not only rescue the innate and adaptive im-
mune system in Lrrc19 KO mice (Figures 4C–4E) but also pro-
moted the accumulation of innate and adaptive immune cells,
including CD4+ and CD8+ T cells, DCs, macrophages, and
immature myeloid cells in the LP (Figure S4B) in WT mice. The
MLN sizes were also significantly larger in mice injected with
chemokine-expressing adenoviral complexes (Figure S4C).
These extra chemokines also increased the sensitivity to DSS-
mediated colitis in Lrrc19 KO mice (Figure 4E) and in WT mice
(Figures S4D and S4E). These data, together, suggest that
LRRC19-associated CCL6, CCL9, CXCL9, and CXCL10 in gut
epithelial cells play a critical role in the recruitment of gut immune
cells.(C) H&E staining and histological scores of representative distal colon samples fro
were assessed according to the methods described in the Supplemental Experi
(D) Incidence of colon carcinoma in WT (n = 18, male) and Lrrc19 KO (n = 18, ma
(E) Morphology and tumor numbers of colon carcinoma in WT and Lrrc19 KO m
(F) Histopathological changes in representative distal colon samples from Lrrc19
(G) Immunostaining of PCNA, COX2, and BrdU in colon tissues of representative
stained by anti-PCNA or anti-COX2 antibodies. For the BrdU assay, mice were in
BrdU antibodies after 4 hr. Brown, PCNA; green, COX2 or BrdU.
Scale bars, 40 mm. *p < 0.05, **p < 0.01 (Wilcoxon’s test in A [top], ANOVA in A
CAltered Gut Microbiota in Lrrc19 KO Mice Affects
Chemokine Expression
We next addressed factor(s) that potentially affect chemokine
expression in gut tissues of Lrrc19 KO mice. Previous studies
have suggested that gut commensal microbiota composition is
important for establishment of the intestinal immune system.
The fewer immune cells in the Lrrc19 KO mice may, therefore,
be attributable to their altered gut microbiota. We first analyzed
fecal microbiotas by pyrosequencing 16S rRNAs in WT and
Lrrc19 KO mice. The animal husbandry, parental genotypes,
and environmental influences were controlled carefully. The
Lrrc19 KO and cohoused WT mice shared the same bacterial
phyla, but, among theirmicrobiotas, the proportions of Firmicutes
andBacteroideteswere significantly different between Lrrc19KO
(29% Firmicutes and 55%Bacteroidetes) andWTmice (59% Fir-
micutes and 34% Bacteroidetes). However, there was a marked
increase in Bacteroidetes and a marked reduction in Firmicutes
in Lrrc19 KO mice compared with WT mice (Figures 5A and 5B;
Table S1). These data were confirmed with 16S rRNA qPCR (Fig-
ure 5C). The relative abundances of bacterial phyla in WT mice
(Figures 5A and 5B; Table S1) were consistent with the data of
other studies (Ley et al., 2006; Turnbaugh et al., 2009). Further an-
alyses showed far fewer Clostridium bacteria in the colons or
Lactobacillus bacteria in the intestines of Lrrc19 KO compared
with WT mice (Table S1). Therefore, we next used a GF mouse
model to demonstrate that the altered gut microbiota in Lrrc19
KOmice is a factor in their reduced levels of chemokines.We first
compared the chemokine levels in the intestinal tissues ofWT and
GF mice. The expression of CCL6, CCL9, CXCL9, and CXCL10
was much lower, or even barely detectable, in the intestinal tis-
sues of GF mice compared with WT mice (Figure 5D). However,
the expression of these chemokines was remarkably higher in
GF mice transplanted with WT mouse feces compared with that
in GF mice transplanted with Lrrc19 KO mouse feces (Figures
5E and 5F), suggesting that the altered gut microbiota in Lrrc19
KOmice affects chemokine expression in their gut epithelial cells.
REGs Are Involved in the Alteration of the Gut
Microbiota in Lrrc19 KO Mice
We next addressed the causes of the altered gut microbiota in
Lrrc19 KO mice. To investigate this, we again analyzed the mi-
croarray data from gut epithelial cells of WT and Lrrc19 KO
mice. The expression of REGs, including REG3a, REG3b,
REG3g, and REG4, was significantly lower in the gut epithelial
cells of Lrrc19 KO mice compared with the gut epithelial cells
of WT mice (Figure 6A; http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE62487). These results were confirmed
with qRT-PCR, immunoblotting, and immunostaining (Figure 6B;mWT and Lrrc19 KO mice on day 7 after the start of DSS. Histological scores
mental Procedures.
le) mice after AOM-2% DSS treatment for 3 months.
ice after AOM-2% DSS treatment for 3 months.
KO and WT mice after staining with H&E.
WT and Lrrc19 KO mice. Colon samples from Lrrc19 KO and WT mice were
jected intraperitoneally with BrdU, and the colon sections were stained by anti-
[bottom], t test in B and D, mean ± SD; Mann-Whitney U test in C and E).
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Figure 3. LRRC19 Deficiency Affects Maturation of Gut-Associated Lymphoid Tissues
(A and B) Visible PP number (A) and sizes (B) in the guts of WT and Lrrc19 KO mice.
(C) Absolute numbers of CD4+T cells, CD8+ T cells, CD11c+MHCII+ cells, F4/80+MHCII+ cells, and CD11b+Gr1+ cells in colon tissues. The absolute numbers were
standardized by calculating the numbers per l cm of colon.
(D) Numbers of CD11c+CD103+CD11bDCs (pp-CD103+DC), CD11C+CD103+CD11b+ DCs (PP-DP-DC), CD11C+CD11bCD103DCs (PP-DNDC), and
CD11C+CD11b+ (PP-CD11b+DC) in PPs as assessed by flow cytometry analysis.
(E and F) Number of CD4+, CD8+, CD4+Foxp3+, CD4+IL-17+, andCD4+IFNg+ T cells in PPs (E) andMLNs (F). Cell numbers in age- and sex-matchedWT (n = 6) and
Lrrc19 KO (n = 6) mice were compared.
*p < 0.05, **p < 0.01 (Mann-Whitney U test). The data are representative of three independent experiments. See also Figures S2 and S3.data not shown). Because the members of the REG family have
the capacity to specifically kill Gram-positive bacteria (Brandl
et al., 2007; Mukherjee et al., 2014; Vaishnava et al., 2011) and
alter the composition of the gut microbiota (Figure 6C), the700 Cell Reports 14, 695–707, February 2, 2016 ª2016 The Authorsreduced expression of REGs in LRRC19 KO mice may explain
their altered gut microbiota.
A critical question is whether the reduced expression of CCL6,
CCL9, CXCL9, and CXCL10 is associated with REG-mediated
Figure 4. LRRC19 Deficiency Reduces the Expression of Chemokines CCL6, CCL9, CXCL9, and CXCL10
(A) Microarray analyses of gene expression in WT and Lrrc19 KO mice given standard chow.
(B) qRT-PCR (top) and immunoblot (bottom) of CCL6, CCL9, CXCL9, and CXCL10 in WT and Lrrc19 KO colon epithelial cells.
(C) Size of visible PP and MLN in L19 KO mice with (KO/CC) or without (KO) CCL6-, CCL9-, CXCL9-, and CXCL10-expressing adenovirus injection.
(D) Absolute number of CD4+ and CD8+ T cells, CD11C+MHCII+ DCs, F4/80MHCII, and CD11b+Gr1+ cells in colon tissue of L19 KOmice with or without (control
adenovirus only) chemokine adenovirus injection as assessed by flow cytometric analysis. CC, CCL6-, CCL9-, CXCL9-, and CXCL10-expressing adenovirus
complexes; WT, cell numbers from the colon tissues of WT mice.
(E) Survival (right) and body weight (left) were monitored until day 14 after the start of DSS. L19 KOmice with (n = 18) or without (n = 18) CCL6, CCL9, CXCL9, and
CXCL10 adenovirus injection were fed a 2% DSS solution in drinking water for 7 days and then switched to regular drinking water.
*p < 0.05, **p < 0.01 (t test in B, mean ± SD; Mann-Whitney U test in C and D; Wilcoxon’s test in E (right); ANOVA in E (left). See also Figure S4.gut microbiotas in Lrrc19 KO mice. To demonstrate this, we first
administrated REG adenoviruses into Lrrc19 KOmice. We found
that the expression of chemokines was much higher in the intes-
tinal tissues of Lrrc19 KOmice with REG adenovirus administra-
tion compared with uninjected mice (Figure 6D), indicating that
the expression of chemokines is related to REG levels in gut tis-
sues. We next addressed whether REG-mediated chemokines
were associated with the gut microbiota of mice administrated
REG adenoviruses. When gut microbiotas of Lrrc19 KO mice
with REG adenoviruses were transplanted into Lrrc19 KO
mice, the expression of chemokines was much higher than inCLrrc19 KOmice transplanted with control feces (Figure 6E), indi-
cating that the altered gut microbiota after administration of REG
adenoviruses affects chemokine expression in their gut epithelial
cells. Taken together, these results suggest that the REG-medi-
ated gut commensal microbiota modulates the expression of
chemokines.
Gut Lactobacillus Directly Regulates the Expression of
REGs through LRRC19-Mediated Activation of NF-kB
Because reduced REGs are responsible for the altered micro-
biota, which caused the decreased chemokine levels in Lrrc19ell Reports 14, 695–707, February 2, 2016 ª2016 The Authors 701
Figure 5. The LRRC19-Associated Gut Microbiota Modulates the Expression of Chemokines
(A and B) 16S rRNA analyses of gut microbiota of WT and Lrrc19 KOmice. The samples were clustered at the operational taxonomic unit (OTU) (A) and phylum (B)
levels using the sample OTU and sample phylum count matrices, respectively.
(C) qRT-PCR of gut microbiota. The abundance of bacteria in WT and Lrrc19 KO mice was measured as bacterium-specific 16S rRNA copy numbers by qPCR
analysis of fecal pellets. Standard curves were prepared from serial dilution of E. coli genomic 16S rRNA extracted in the same manner as above.
(D) qRT-PCR and immunoblot of CCL6, CCL9, CXCL9, and CXCL10 in WT and GF mice.
(E) qRT-PCR and immunoblot of CCL6, CCL9, CXCL9, and CXCL10 in GF+WT and GF+L19KOmice. GF+WT, GFmice transplanted with the microbiota from the
feces of WT mice; GF+L19KO, GF mice transplanted with microbiota from the feces of Lrrc19 KO mice.
(F) Immunostaining of CCL6, CCL9, CXCL9, and CXCL10 in GF+WT and GF+L19KO mice. Scale bars, 40 mm.
*p < 0.05, **p < 0.01 (Mann-Whitney U test in C; t test in D and E, mean ± SD). See also Table S1.KO mice, we next explored how LRRC19 affects the expression
of REGs. LRRC19, as a potential bacterium recognition receptor,
may be activated by gut bacteria to regulate the expression of
REGs. The genus Lactobacillus was decreased remarkably in702 Cell Reports 14, 695–707, February 2, 2016 ª2016 The AuthorsLrrc19 KO mice (Table S1). Therefore, the reduced expression
of the REGs in Lrrc19 KO mice may be caused by the decrease
in Lactobacillus. After screening the isolated gut commensal
bacteria, we identified the strain of Lactobacilluswith the highest
Figure 6. Expression of Chemokines Is Associated with the REG-Mediated Microbiota
(A) Microarray analysis of gene expression in gut tissues of WT and Lrrc19 KO mice.
(B) qRT-PCR (top) and immunoblot (bottom) of REG3a, REG3b, REG3g, and REG4 in WT and Lrrc19 KO colon tissues.
(C) qRT-PCR of gut microbiotas. The abundance of bacteria in L19 KO mice with (KO/REGs) or without (KO, control adenoviruses only) REG3a-, REG3b-,
REG3g-, and REG4-expressing adenovirus injection was measured as 16S rRNA copy numbers by qPCR analysis of fecal pellets. Standard curves were pre-
pared from serial dilution of E. coli genomic 16S rRNA extracted in the same manner as above.
(D) qRT-PCR and immunoblot of CCL6, CCL9, CXCL9, and CXCL10 in L19 KO mice with or without (control adenoviruses only) REG adenovirus injection.
Adenovirus-Reg3a, -Reg3b, -Reg3g, and -Reg4 complexes (REG) or control adenovirus were injected intraperitoneally once per week, three times.
(E) qRT-PCR and immunoblot of CCL6, CCL9, CXCL9, and CXCL10 in feces-transplanted mice. Mice were first treated using pan-antibiotics (1 g/l ampicillin,
Sigma), 0.5 g/l vancomycin, 1 g/l neomycin sulfate, and 1 g/l metronidazole) in drinking water for 4 weeks andwere then transplantedwithmicrobiotas from feces.
WT(fe), Lrrc19KOmice transplanted with themicrobiota from the feces ofWTmice; L19KO(fe), Lrrc19 KOmice transplanted with themicrobiota from the feces of
Lrrc19 KO mice with control adenovirus injection; L19KO/REG(fe), Lrrc19 KO mice transplanted with the microbiota from the feces of REG adenovirus-
administered Lrrc19 KO mice. Expression of CCL6, CCL9, CXCL9, and CXCL10 was analyzed 3 days after transplantation.
*p < 0.05, **p < 0.01 (Mann-Whitney U test in C; t test in D and E, mean ± SD). See also Figures S5, S6, and S7.similarity to Lactobacillus taiwanensis strain BCRC 17755,
LactobacillusNK6 (colony 6) (Figure S5). This strain could induce
the expression of REGs in gut epithelial cells (Figures S6A and
S6B). Notably, lactobacilli could activate the intracellular NF-
kB signaling pathway in LRRC19- but not DLRRC19-transfected
(absence of an extracellular region) HEK293T cells (Figure S6C).
All of these data suggest that LRRC19 may directly regulate the
expression of REGs.
We next dissected the molecular pathways by which LRRC19
signaling regulates the expression of REG family proteins.
LRRC19 deficiency affected the phosphorylation of p65, p38,
and c-Jun N-terminal kinase (JNK) in response to Lactobacillus
(Figure S7A), indicating that LRRC19 activates multiple signalingCpathways. Consistent with previous findings (Su et al., 2014),
there was more K63-linked ubiquitin on the TRAF6 from WT
gut epithelial cells than on TRAF6 from Lrrc19 KO cells (Fig-
ure S7B). The ubiquitination of TRAF2 was also inhibited mark-
edly in WT gut epithelial cells, whereas the ubiquitination of
TRAF2 in Lrrc19 KO cells was increased greatly in response to
Lactobacillus NK6 (Figure S7C). Because TRAF2 and TRAF6
are critical adaptor molecules of NF-kB signaling pathways, we
also examined the effect of NF-kB deficiency on the expression
of REG family members. The expression of REG family members
such as REG3a, REG3b, REG3g, and REG4 was lower in NF-kB
KO mice than in WT mice (Figure S7D). NF-kB KO mouse gut
epithelial cells had a highly reduced response to Lactobacillusell Reports 14, 695–707, February 2, 2016 ª2016 The Authors 703
NK6 (Figure S7E), implying that LRRC19 mediates the expres-
sion of REG3 family members through NF-kB signaling path-
ways. This is consistent with previous findings (Vaishnava
et al., 2011). These results suggest that LRRC19 mediates the
expression of REG proteins through the TRAF2- and TRAF6-
mediated NF-kB signaling pathways.
Exogenous LRRC19 Promotes the Occurrence and
Development of Colitis
Finally, we examined the importance of LRRC19 in promoting
the recruitment of immune cells and intestinal inflammation.
LRRC19-expressing adenovirus was injected intraperitoneally
three times per week, with demonstrable infection (Figure 7A).
This treatment increased the sensitivity ofmice to DSS-mediated
colitis (Figure 7B) and AOM-DSS-induced colon cancer (Fig-
ure 7C). The administration of LRRC19-expressing adenovirus
also increased the infiltration of different immune cells into the
gut tissues (Figure 7D) and altered the immune cell proportions
in that the CD103+CD11b+ cell population in the LP increased
dramatically in mice administered LRRC19-expressing adeno-
virus and the Th1+ (IFNg+) and Th17+ cell subsets in the PPs
andMLNs also increased (data not shown). qRT-PCR and immu-
noblot analyses showed that CCL6, CCL9, CXCL9, and CXCL10
expression in mice administered LRRC19-expressing adeno-
virus was also higher than in control mice (Figures 7E and 7G).
Expression of the REG family proteins REG3a, REG3b, REG3g,
and REG4 was higher in adenovirus-treated mice than in mice
injected with the control vector (Figures 7F and 7G). All of these
data confirm the critical role of LRRC19 in the recruitment of im-
mune cells and intestinal inflammation.
DISCUSSION
Gut epithelial cells express multiple pattern recognition recep-
tors, such as TLRs and Nod-like receptors, that play important
roles in eliminating pathogenic microorganisms. However, the
expression levels of these TLRs are too low under normal phys-
iological conditions to produce a responsive to TLR stimuli
(Melmed et al., 2003). Therefore, it is not really clear what type
of receptors plays a critical role in the establishment and matu-
ration of the gut immune system. We found that LRRC19, which
does not contain a cytoplasmic Toll/interleukin 1 receptor
domain, determines the recruitment of immune cells and intesti-
nal inflammation under normal physiological conditions. Unlike
the pathogen-recognizing receptors, LRRC19 is highly ex-
pressed on gut epithelial cells and directly mediates the
TRAF2- and TRAF6 NF-kB signaling pathways in gut epithelial
cells.
Mining the microbiota for bacterial strains that are responsible
for shaping the gut immune system is a formidable combinatorial
problem. Although some progress has been made in identifying
gut microbe species that preferentially stimulate a specific pro-
gram of immune maturation, the gut-specific commensal micro-
biota for maintaining the maturation of the whole gut immune
system is largely unknown. We found that gut commensal mi-
crobes of the genus Lactobacillus are involved in this process.
Although the particular bacterial products are unknown, we
demonstrated that Lactobacillus may promote the expression704 Cell Reports 14, 695–707, February 2, 2016 ª2016 The Authorsof REG3a, REG3b, and REG3g through LRRC19-mediated
TRAF2- and TRAF6 NF-kB signaling pathways in gut epithelial
cells. This may affect the recruitment of immune cells and intes-
tinal inflammation by gut microbiota-mediated chemokines.
Lactobacillus are Gram-positive bacteria with the cell wall
component peptidoglycan. Recognition of peptidoglycan is
important in initiating and shaping the immune response under
both homeostatic and infection conditions (Sorbara and Philpott,
2011). Indeed, four other secreted peptidoglycan recognition
proteins, PGLYRP 1-4, as well as two intracellular sensors of
peptidoglycan, Nod1 and Nod2, also have important roles in
shaping mammalian immune responses (Sorbara and Philpott,
2011).
Our study establishes an LRRC19-based regulatory axis that
may promote the recruitment of immune cells and intestinal
inflammation. Chemokines CCL6, CCL9, CXCL9, and CXCL10
may directly recruit immune cells into the gut tissues, whereas
REG family proteins, including REG3a, REG3b, REG3g, and
REG4, play critical roles by affecting the composition of the
gut microbiota, which may modulate chemokine expression.
Commensal microbes of the genus Lactobacillus are essential
for the establishment of the gut immune system by activating
the LRRC19-mediated signaling pathway, which may induce
the expression of REG family proteins such as REG3a, REG3b,
and REG3g. These results represent an important advance in un-
derstanding how gut commensal microbes exert their effects to
promote the recruitment of immune cells and intestinal inflam-
mation through the microbe receptors expressed on gut epithe-
lial cells. This will be invaluable when designing therapeutic
strategies for colitis and colitis-associated diseases such as
colon carcinoma.
EXPERIMENTAL PROCEDURES
Mice
Four-to six-week-old male or female C57BL/6 and GFP transgenic C57BL/6
mice were obtained from the Beijing Animal Center. Lrrc19 KO mice were
generated by us (Su et al., 2014). Tlr2 KOmice were obtained from the Nanjing
Animal Center. Nf-kb KO (p50/) mice were provided by Prof. Zhexiong Lian
(University of Science and Technology of China). Germ-free mice were gener-
ated by the Third Military Medical University and were bred and maintained in
sterile Trexler-type isolators. All procedures were conducted according to the
Institutional Animal Care and Use Committee of the Model Animal Research
Center. Animal experiments were approved by the Animal Ethics Committee
of Nankai University.
Preparation of Specific Experimental Mice
Chimeric mice were generated according to our previously published method
(Su et al., 2014). Briefly, 6-week-old Lrrc19KOandWTGFP transgenic C57BL/
6mice were lethally irradiated with 9 Gy of total body irradiation. BM cells were
obtained from the femora of donor mice and collected in RPMI 1640 medium
containing 100 U/ml penicillin/streptomycin. Irradiated recipient mice were in-
jected with 200 ml of the appropriate cell suspension via the tail vein. The recip-
ient mice were maintained in a sterile facility for 8 weeks to allow for complete
engraftment with donor bone marrow. To assay bone marrow reconstitution,
spleens were harvested from chimeric mice, and single-cell suspensions of
splenocytes were prepared in PBS and then analyzed by flow cytometry to
detect GFP+ spleen cells and to determine the donor/recipient chimerism of
the hematopoietic compartment.
For microbiota transplantation mice, cecal contents were pooled from five
mice. Cecal contents (150 mg) were collected in an anaerobic chamber,
suspended in 1 ml PBS, and immediately administered intragastrically
Figure 7. Exogenous LRRC19 Promotes the Occurrence and Development of Gut Inflammation
(A) qRT-PCR (top) and immunoblot (bottom) of LRRC19 in LRRC19 adenovirus- (WT+ade) or control adenovirus (WT+NC)-injectedmice. Colon tissueswere lysed
and analyzed for LRRC19 expression by anti-hemagglutinin (HA), with which LRRC19 was tagged in adenoviruses.
(B) Survival (top) and body weight (bottom) were monitored until day 14 after the start of DSS. Mice with (Ade) and without LRRC19 (NC) adenovirus injection
(n = 16, male) were fed a 2% DSS solution in drinking water for 7 days and then switched to regular drinking water.
(C) Experimental design (top) and incidence and tumor numbers (bottom) of colon carcinoma in LRRC19 adenovirus- (WT+ade) (n = 16) or control adenovirus-
administered (WT+NC) mice (n = 16) after AOM-2% DSS treatment for 3 months.
(D) Absolute number of CD4+T cells, CD8+ T cells, CD11C+MHCII+ DCs, F4/80+MHCII+, and CD11b+Gr1+ cells in colon tissues of LRRC19 adenovirus- (AdeL19)
or control adenovirus (NC)-injected mice (n = 6) as assessed by flow cytometry. The absolute numbers were standardized by calculating the numbers per l cm of
colon.
(E, F, and G) qRT-PCR (E and F) and immunoblot (G) of CCL6, CCL9, CXCL9, and CXCL10 and REG3a, REG3b, REG3g, and REG4 in LRRC19 adenovirus
(AdeL19)- or control adenovirus (NC)-injected mice (n = 6). Lanes 1–3 in (G) are representatives of six mice.
*p < 0.05, **p < 0.01 (Wilcoxon’s test in B [top]; ANOVA in B [bottom]; t test in A, C, D, E, and F, mean ± SD; Mann-Whitney U test in C for tumor number).
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(0.1 ml/mouse) to sterilely packed, 6- to 7-week-old germ-free mice or pan-
antibiotic-treatedmice. TheLactobacillusNKcolonywas selected andcultured
in Lactobacillus-selective medium, suspended in PBS, and immediately
administered intragastrically (1 3 109 colony-forming units [CFUs]/mouse) to
sterilely packed, 6- to7-week-old mice three times per week for 4 weeks.
For mice expressing exogenous LRRC19; chemokine or REG; adenovirus-
LRRC19, -CCL6, -CCL9, -CXCL9, and -CXCL10 complexes (CC); or adeno-
virus-Reg3a, -Reg3b, -Reg3g, and –Reg4 complexes (REG) were injected
intraperitoneally at the indicated time. The expression of LRRC19, CCL6,
CCL9, CXCL9, and CXCL10 or Reg3a, Reg3b, Reg3g, and Reg4 in gut epithe-
lial cells was determined using qRT-PCR and immunoblotting.
Isolation of the Gut Lactobacillus Strain Lactobacillus NK6
For isolation of the gut microbiota, the cecal contents fromWTmice were seri-
ally diluted with PBS and seeded onto Lactobacillus-selective culture plates.
After culture under aerobic conditions or strictly anaerobic conditions at
37C for 24–48 hr, individual colonies were picked up and cultured for an addi-
tional 1–2 days at 37C in Lactobacillus-selective medium (LactobacillusMRS
medium) (per liter: protease peptone, 10.0 g; beef extract, 10.0 g; yeast
extract, 5.0 g; Tween 80, 1.0 ml; ammonium citrate, 2.0 g; sodium acetate,
5.0 g; magnesium sulfate, 0.1 g; manganese sulfate, 0.05 g; di-potassium
phosphate, 2.0 g; and glucose at 2% [w/v]). The isolated colonies were
collected into stock medium (10% glycerol) and stored at 80C. The se-
quences of the 16S rRNAs of the isolated colonies were obtained by cycle
sequencing and were then aligned with the 16S rRNA database of GenBank
using BLAST. Each inquiry gave the 100 most similar sequence results,
including different bacterial genera. For each genus, one bacterial strain with
the highest Max Score was selected, and its sequence was downloaded.
Next, all obtained sequences were aligned by MUSLE, and then the
neighbor-joining method was used to construct a phylogenetic tree.
Flow Cytometry
Single-cell suspensions of MLNs, PPs, and spleen were prepared by mashing
them in a cell strainer (70 mm), stained, and analyzed by flow cytometry. For
the staining of lamina propria lymphocytes, gut epithelial cells were first
removed using 1 mM EDTA and then digested in RPMI medium with 5% fetal
bovine serum (FBS) and 0.15% collagenase II (275 U/mg)/0.05% dispase
(1.1 U/mg) (Invitrogen) for 1 hr at 37C. LP cells were filtered tominimizemucus
contamination, stained, and analyzed by flow cytometry. Dead cells were elim-
inated through PI staining.
For intracellular staining, cells were cultured and stimulated for 16 hr
with 50 ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma) and 1 mg/ml ion-
omycin (Sigma) in the presence of GolgiStop (10 ng/ml, BD Biosciences). After
incubation for 16 hr, cells were washed in PBS, and surface CD4 was stained
with a fluorescein isothiocyanate (FITC)- or phycoerythrin (PE)-labeled
anti-CD4 antibody. Cells were then washed, fixed in Cytofix/Cytoperm,
permeabilized with perm/wash buffer (BD Biosciences), and stained with
PE- or FITC-labeled anti-IFNg, anti-Th17, or anti-Foxp3. Meanwhile, dead
cells were eliminated through PI staining.
In Vitro Stimulation
For in vitro stimulation, gut epithelial crypts were stimulated for 12 hr using
bacteria (crypt cells: bacteria = 1:100) and then lysed for immunoblot analyses.
To isolate crypts, samples were transferred to 5 mM EDTA in PBS (pH 8),
shaken by hand for 1 min, incubated at 4C for 15 min, and passaged through
70-mm filters (BD Falcon) to collect the flowthrough. The fraction containing
intact and isolated crypts was collected by centrifugation at 75 3 g for 5 min
at 4C and washed once with PBS. In some cases, bacteria (1 3 107) were
injected directly into colon segments to stimulate colon epithelial cells, and
then colon epithelial cells were isolated using 5 mM EDTA.
RT-PCR and qRT-PCR
RT-PCR and qRT-PCR were performed according to methods published pre-
viously (Su et al., 2014). Total RNA was extracted from the cells, tissues, and
organs using TRIzol reagent (Invitrogen). First-strand cDNA was generated
from total RNA using oligo-dT primers and reverse transcriptase (Invitrogen).
The PCR products were visualized on 1.0% (WT/v) agarose gels. qRT-PCR706 Cell Reports 14, 695–707, February 2, 2016 ª2016 The Authorswas conducted using QuantiTect SYBR Green PCR Master Mix (QIAGEN)
and specific primers in an ABI Prism 7000 analyzer (Applied Biosystems).
GAPDH mRNA expression was detected in each experimental sample as an
endogenous control. All reactions were run in triplicate.
Immunoprecipitation and Immunoblot Analysis
Immunoprecipitation and immunoblot analysis were performed according to
methods published previously (Su et al., 2014). The cells were lysed with cell
lysis buffer (Cell Signaling Technology) supplemented with a protease inhibitor
‘‘cocktail’’ (Calbiochem). Immunoprecipitation (IP) was performed essentially
as described by Thermo Scientific. For the immunoblot, hybridizations with
primary antibodies were conducted for 1 hr at room temperature in blocking
buffer. The protein-antibody complexes were detected using peroxidase-
conjugated secondary antibodies (Boehringer Mannheim) and enhanced
chemiluminescence (Amersham).
Statistical Analysis
Student’s t test, one-way ANOVA, Bonferroni’s multiple comparison test, Wil-
coxon’s test, and Mann-Whitney U test were used to determine significance.
A 95% confidence interval was considered significant and was defined as
p < 0.05 (*p < 0.05, **p < 0.01, ***p < 0.001).
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